Navigation Links
Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
Date:6/17/2008

BELLEVUE, WA, June 17 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY) today announced enrollment of the first patient in a Phase 1 trial of PX-866 in patients with advanced solid tumors. PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), an important cell survival signaling pathway.

"PX-866 is a potent inhibitor of PI-3K, a component of a critical pathway that is activated in many types of cancer, leading to tumor growth and survival," said Lynn Kirkpatrick, Ph.D., Chief Scientific Officer of Oncothyreon. "We believe that the mechanism of action of PX-866, which irreversibly inhibits PI-3K, will have pharmacokinetic and pharmacodynamic advantages that will distinguish PX-866 in the competitive field of PI-3K inhibitors."

The Phase 1 trial is expected to enroll up to 63 patients with advanced metastatic cancer who have failed or are intolerant of standard therapy. Patients will receive PX-866 orally once per day on days 1 through 5 and 8 through 12 during a four-week treatment cycle. Primary objectives of the study include establishment of a maximum tolerated dose, evaluation of safety, and analysis of the pharmacodynamic and pharmacokinetic profiles of PX-866.

"The start of the PX-866 trial represents a significant milestone for Oncothyreon, as we now have three active clinical programs underway for our promising small molecule inhibitors," said Robert L. Kirkman, M.D., President and CEO of Oncothyreon. "Together with our therapeutic vaccine programs, we have successfully established a broad and diverse oncology pipeline targeting multiple cancer indications with substantial unmet medical need, and we look forward to sharing the ongoing pro
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Biomira announces plan to change name to Oncothyreon
2. Oncothyreon highlights corporate and clinical objectives for 2008
3. Oncothyreon to present at BIO CEO & Investor Conference
4. Oncothyreon launches new corporate website
5. Oncothyreons PX-478 is effective in preclinical model of human lung cancer
6. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
7. Oncothyreon reports full year and fourth quarter 2007 financial results
8. Oncothyreon to present at upcoming investment conferences
9. Oncothyreon announces issuance of patent for PX-867
10. Oncothyreon announces effectiveness of shelf registration statement
11. Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 Can economic ... from work motivate members of the public to increase ... including Johns Hopkins Carey Business School Assistant ... yes. Pointing to a large body of recent research ... the May 24, 2013, issue of Science that the ...
(Date:5/23/2013)...  Rahal Letterman Lanigan Racing (RLL) and StemCyte, Inc., ... banking and therapeutics, announced today that StemCyte has become ... Indy car driven by James Jakes ... IndyCar 2013 season.   StemCyte, Inc. and Rahal ... of umbilical cord blood banking and its educational initiative ...
(Date:5/23/2013)... HILLS, Calif. , May 23, 2013  Saddleback ... recently became the first hospital on the ... robotic technology. This new surgical option provides women with ... Marc Winter , M.D., ... gynecologist and surgeon and medical director of minimally invasive ...
(Date:5/23/2013)... -- Z Trim Holdings, Inc. (OTC Markets: ZTHO), a ... industries, announced that Chef Erin Ryan ... National Restaurant Association ("NRA") NRA Show, which was held ... Chefs Association.  Chef Ryan spoke on the subject of ... the Ugly," joining four other prestigious panelists including:  Kit ...
Breaking Biology Technology:Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3
... -- China Medicine Corporation,(OTC Bulletin Board: CHME) ... and distributor of prescription and over the ... dietary supplements, and,medical devices and medical formulations ... (Good Supply Practice for Pharmaceutical Products) certification,from ...
... HANGZHOU, China, Dec. 1 /PRNewswire-Asia/ -- Tigermed ... (CRO) in China, announced that it has,established ... Ltd, with Central, South University (CSU). ... participation in the construction of a nationwide ...
... Inc.,(Nasdaq: NVAX ) a clinical-stage vaccine company, ... Officer, will be presenting at,the Piper Jaffray 20th Annual ... in New York. Dr. Singhvi will provide an overview ... to the live,presentation can be accessed via the Company ...
Cached Biology Technology:China Medicine Corporation Awarded GSP Certification 2China Medicine Corporation Awarded GSP Certification 3Tigermed Sets Up Subsidiary, Hunan Tigermed Xiangya Drug R&D Ltd (Tigermed Xiangya) 2
(Date:5/22/2013)... durability in fuel cell powered buses, including a ... between electrode degradation processes and bus membrane durability. ... electrode degradation stressors in the operating cycle of ... findings of the study, led by SFU graduate ... long-term study at Burnaby-based Ballard Power Systems and ...
(Date:5/22/2013)... human health effects from disposal of millions of ... to recommend stronger government policies to encourage recovery, ... That,s the conclusion of a new paper in ... . , Oladele A. Ogunseitan and colleagues point ... powering everything from smart phones to components in ...
(Date:5/22/2013)... Declines in the biodiversity of pollinating insects and wild ... new study. , Researchers led by the University of ... found evidence of dramatic reductions in the diversity ... the 1950s and 1980s. , But the picture brightened ... national biodiversity losses among bees, hoverflies and wild plants. ...
Breaking Biology News(10 mins):Tests lead to doubling of fuel cell life 2Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... of locally and regionally grown food is on the ... for those with limited financial resources. Virginia Tech,s College ... Virginia University and North Carolina State University to develop, ... the resiliency of the Southern Appalachian region, with a ...
... in New Zealand have identified the direct impact of ... decline of the endangered native sea lion population. The ... non-human factors, such as disease and identifies resource competition ... The New Zealand sea lion Phocarctos hookeri is the ...
... of molecular scientists have discovered that star ascidians, also known ... the human heart. The research, published in the JEZ ... insight into the early evolution of the heart as star ... The research team, led by Annette Hellbach from the ...
Cached Biology News:Virginia Tech leads study to improve food security in southern Appalachia 2Virginia Tech leads study to improve food security in southern Appalachia 3Competition with humans responsible for decline of New Zealand's endangered sea lions, study shows 2Sea squirt pacemaker gives new insight into evolution of the human heart 2
... LV Series offers high performance miniature stepper ... 23, and 34 frame sizes. These space-efficient ... life science applications, including medical instrumentation, medical ... automation systems., Meets a wide range ...
... nitrogen base (YNB) is a base medium for ... YNB contains ammonium sulfate but does not contain ... are available. Each pouch contains reagents to ... media or 1000 ml of 10X YNB for ...
... Designed for use with dishes and cell ... a new product number, created to easily ... availability yet, please order under the old ... for assistance. Comp Dim: blade L 1.9 ...
... CHEMICONs Alkaline Phosphatase Detection Kit (Catalog number ... for the phenotypic assessment of ES cell ... Available separately from CHEMICON are the ... TRA-2-54 (Catalog Number MAB4354), which permit the ...
Biology Products: